Mark T Iwicki, Director at Aimmune Therapeutics, holds 0.00 shares in Merus (Ticker: MRUS), holds 0.00 shares in Akero Therapeutics (Ticker: AKRO), holds 103.54K shares in KALA BIO (Ticker: KALA).
What is the percentage of profitable transactions made by Mark T Iwicki?
The percentage of profitable transactions made by Mark T Iwicki is 50%.
What is the average return per transaction made by Mark T Iwicki?
The average return per transaction made by Mark T Iwicki is 1.70%.
What stocks does Mark T Iwicki hold?
Mark T Iwicki holds: AIMT, KALA, PULM, AKRO, MRUS, JBIO, THRD, QTTB, IKT stocks.
What was Mark T Iwicki’s latest transaction?
Mark T Iwicki latest transaction was an Uninformative Sell of $7.14M.
What was Mark T Iwicki's most profitable transaction?
Mark T Iwicki’s most profitable transaction was an Informative Sell of KALA stock on October 24, 2025. The return on the trade was 21.70%.
What is Mark T Iwicki's role in Aimmune Therapeutics?
Mark T Iwicki's role in Aimmune Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.